Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First prenatal replacement therapy presented for rare form of dystonia

June 20, 2012

Promising first-in-human daratumumab results presented at recent meetings

June 19, 2012

Ongoing congress features data from first PD trial assessing exenatide efficacy/safety/tolerability

June 19, 2012

ChemoCentryx compound shows efficacy in diabetic nephropathy model

June 19, 2012

RDX-5791 studied for effects on sodium excretion in healthy volunteers

June 19, 2012

Novel PPAR-gamma agonist tested in polycystic kidney disease model

June 19, 2012

U.S. study links SNPs to aggressive prostate cancer and associated mortality

June 19, 2012

First clinical data disclosed on Bristol-Myers Squibb drug for cancer

June 18, 2012

Phase II study tests iron chelator in adults with transfusional iron overload

June 18, 2012

First-in-human data presented on oncolytic BAY-1000394

June 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...